Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2081-2026

Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485 Recall

Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485

FDA recall Class II

Ongoing

FDA lists this Class II recall for Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2081-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Apr 1, 2026
FDA report date
May 13, 2026
Quantity in commerce
2400 pouches
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485

Affected model & UDI checker

Search the exact identifiers published for Z-2081-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
423485Biofire Spotfire Respiratory/Sore Throat Panel REF: 423485Check source noticeNot specified
Not specifiedBiofire Spotfire Respiratory/Sore Throat Panel REF: 423485Check source notice00815381020390
FDA code information

Lot Number: 2215125/UDI: 00815381020390

View the original FDA recall notice

Why was this product recalled?

Respiratory/sore throat panel test may result in false negative results and control failures.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Biofire Diagnostics, LLC take?

On April 1, 2026, Biomerieux, issued a "Urgent Medical Device Recall" via E-Mail. Biomerieux ask consignees to take the following actions: In this context, we request that you take the following actions: " Examine your inventory for the lot identified in this recall notice. "Discontinue use and discard any remaining product from this lot in your possession. "Please confirm the quantity of kits that have been destroyed, previously used, or returned on the attached Acknowledgement of Receipt Form. "If you have further distributed this product, please identify any recipients and notify them at once. " Please complete the accompanying Acknowledgement of Receipt Form and return to bioMrieux.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology